Insulin-like growth factor (IGF) system in liver diseases
A Adamek, A Kasprzak - International journal of molecular sciences, 2018 - mdpi.com
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors
produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to …
produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to …
Insulin-like growth factor-1 deficiency and metabolic syndrome
GA Aguirre, JR De Ita, RG De La Garza… - Journal of translational …, 2016 - Springer
Consistent evidence associates IGF-1 deficiency and metabolic syndrome. In this review, we
will focus on the metabolic effects of IGF-1, the concept of metabolic syndrome and its …
will focus on the metabolic effects of IGF-1, the concept of metabolic syndrome and its …
Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease
Obesity and liver diseases are associated with the disruption of the circadian clock that
orchestrates mammalian physiology to optimize nutrient metabolism and storage. Here, we …
orchestrates mammalian physiology to optimize nutrient metabolism and storage. Here, we …
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
JE Puche, I Castilla-Cortázar - Journal of translational medicine, 2012 - Springer
Insulin-like growth factor I (IGF-I) is a polypeptide hormone produced mainly by the liver in
response to the endocrine GH stimulus, but it is also secreted by multiple tissues for …
response to the endocrine GH stimulus, but it is also secreted by multiple tissues for …
Gonadal dysfunction in systemic diseases
A Karagiannis, F Harsoulis - European Journal of Endocrinology, 2005 - academic.oup.com
Gonadal function is significantly affected in many acute and chronic systemic diseases. As
the function of the testes and the ovaries is determined by the integrity of the hypothalamic …
the function of the testes and the ovaries is determined by the integrity of the hypothalamic …
Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid
S Padmanabhan, DN Tripathi, A Vikram… - … /genetic toxicology and …, 2009 - Elsevier
Methotrexate (MTX) is an anti-metabolite widely used in the treatment of neoplastic
disorders, rheumatoid arthritis and psoriasis. The basis for its therapeutic efficacy is the …
disorders, rheumatoid arthritis and psoriasis. The basis for its therapeutic efficacy is the …
[PDF][PDF] Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver
J Heo, VM Factor, T Uren, Y Takahama, JS Lee… - …, 2006 - Wiley Online Library
We established an efficient system for differentiation, expansion and isolation of hepatic
progenitor cells from mouse embryonic stem (ES) cells and evaluated their capacity to …
progenitor cells from mouse embryonic stem (ES) cells and evaluated their capacity to …
Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats
JE Puche, M García-Fernández, J Muntané… - …, 2008 - academic.oup.com
Serum IGF-I levels decline with age. We have recently reported that in aging rats the
exogenous administration of IGF-I restores IGF-I circulating levels and age related-changes …
exogenous administration of IGF-I restores IGF-I circulating levels and age related-changes …
Is insulin-like growth factor-1 involved in Parkinson's disease development?
I Castilla-Cortázar, GA Aguirre, G Femat-Roldán… - Journal of translational …, 2020 - Springer
Parkinson's disease (PD) is a neurodegenerative disorder that results in the death of
dopaminergic neurons within the substantia nigra pars compacta and the reduction in …
dopaminergic neurons within the substantia nigra pars compacta and the reduction in …
Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial
M Conchillo, RJ de Knegt, M Payeras, J Quiroga… - Journal of …, 2005 - Elsevier
BACKGROUND/AIMS: Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized
in the liver whose levels decrease sharply in liver cirrhosis. METHODS: We conducted a …
in the liver whose levels decrease sharply in liver cirrhosis. METHODS: We conducted a …